- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2013 (2013), Article ID 798403, 8 pages
Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases
1Tunnell Cancer Center, Beebe Medical Center, Rehoboth Beach, DE 19971, USA
2Stanford University, Stanford, CA 94304, USA
3University of Michigan Hospital, Ann Arbor, MI 48109, USA
4Hadassah Hebrew University Medical Center, Jerusalem, Israel
5Johns Hopkins Hospital, Baltimore, MD 21287, USA
Received 16 April 2013; Revised 22 July 2013; Accepted 30 July 2013
Academic Editor: Chandrajit Premanand Raut
Copyright © 2013 Jennifer Hung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. G. West, A. Qureshi, J. E. West et al., “Risk of angiosarcoma following breast conservation: a clinical alert,” Breast Journal, vol. 11, no. 2, pp. 115–123, 2005.
- A. T. Monroe, S. J. Feigenberg, and N. P. Mendenhall, “Angiosarcoma after breast-conserving therapy,” Cancer, vol. 97, no. 8, pp. 1832–1840, 2003.
- S. A. Vorburger, Y. Xing, K. K. Hunt et al., “Angiosarcoma of the breast,” Cancer, vol. 104, no. 12, pp. 2682–2688, 2005.
- J. Rao, J. G. DeKoven, J. D. Beatty, and G. Jones, “Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast,” Journal of the American Academy of Dermatology, vol. 49, no. 3, pp. 532–538, 2003.
- A. Selim, A. Khachemoune, and N. A. Lockshin, “Angiosarcoma: a case report and review of the literature,” Cutis, vol. 76, no. 5, pp. 313–317, 2005.
- W. G. Cahan, H. Q. Woodard, N. L. Higinbotham, F. W. Stewart, and B. L. Coley, “Sarcoma arising in irradiated bone: report of eleven cases. 1948,” Cancer, vol. 82, no. 1, pp. 8–34, 1998.
- M. Arlen, N. L. Higinbotham, A. G. Huvos, R. C. Marcove, T. Miller, and I. C. Shah, “Radiation-induced sarcoma of bone,” Cancer, vol. 28, no. 5, pp. 1087–1099, 1971.
- M. Tahir, P. Hendry, L. Baird, N. A. Qureshi, D. Ritchie, and P. Whitford, “Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery,” International Seminars in Surgical Oncology, vol. 3, article 26, 2006.
- S. D. Billings, J. K. McKenney, A. L. Folpe, M. C. Hardacre, and S. W. Weiss, “Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases,” American Journal of Surgical Pathology, vol. 28, no. 6, pp. 781–788, 2004.
- E. De Bree, F. Van Coevorden, J. L. Peterse, N. S. Russell, and E. J. T. Rutgers, “Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition?” European Journal of Surgical Oncology, vol. 28, no. 4, pp. 392–395, 2002.
- R. Komdeur, H. J. Hoekstra, W. M. Molenaar et al., “Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target,” Clinical Cancer Research, vol. 9, no. 8, pp. 2926–2932, 2003.
- H. Nakanishi, Y. Tomita, A. Myoui et al., “Mutation of the p53 gene in postradiation sarcoma,” Laboratory Investigation, vol. 78, no. 6, pp. 727–733, 1998.
- A. Broeks, J. H. M. Urbanus, A. N. Floore et al., “ATM-heterozygous germline mutations contribute to breast cancer-susceptibility,” American Journal of Human Genetics, vol. 66, no. 2, pp. 494–500, 2000.
- A. Nocito, J. Kononen, O.-P. Kallioniemi, and G. Sauter, “Tissue microarrays (TMAS) for high-throughput molecular pathology research,” International Journal of Cancer, vol. 94, no. 1, pp. 1–5, 2001.
- S. De Vos, S. P. Wilczynski, M. Fleischhacker, and P. Koeffler, “p53 Alterations in uterine leiomyosarcomas versus leiomyomas,” Gynecologic Oncology, vol. 54, no. 2, pp. 205–208, 1994.
- A. Liu, T. Takakuwa, S. Fujita et al., “Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma,” Laboratory Investigation, vol. 85, no. 3, pp. 436–446, 2005.
- L. J. A. Strobbe, H. L. Peterse, H. Van Tinteren, A. Wijnmaalen, and E. J. T. Rutgers, “Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela,” Breast Cancer Research and Treatment, vol. 47, no. 2, pp. 101–110, 1998.
- J. Huang and W. J. Mackillop, “Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma,” Cancer, vol. 92, no. 1, pp. 172–180, 2001.
- J. Fodor, Z. Orosz, É. Szabó et al., “Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature,” Journal of the American Academy of Dermatology, vol. 54, no. 3, pp. 499–504, 2006.
- J. M. Seinen, E. Styring, V. Verstappen et al., “Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resection,” Annals of Surgical Oncology, pp. 1–7, 2012.
- N. C. Hodgson, C. Bowen-Wells, F. Moffat, D. Franceschi, and E. Avisar, “Angiosarcomas of the breast: a review of 70 cases,” American Journal of Clinical Oncology, vol. 30, no. 6, pp. 570–573, 2007.
- C. Fraga-Guedes, H. Gobbi, M. G. Mastropasqua, E. Botteri, A. Luini, and G. Viale, “Primary and secondary angiosarcomas of the breast: a single institution experience,” Breast Cancer Research and Treatment, vol. 132, no. 3, pp. 1–8, 2011.
- C. Tomasini, M. Grassi, and M. Pippione, “Cutaneous angiosarcoma arising in an irradiated breast: case report and review of the literature,” Dermatology, vol. 209, no. 3, pp. 208–214, 2004.
- T. Brenn and C. D. M. Fletcher, “Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopothologic analysis of 42 cases,” American Journal of Surgical Pathology, vol. 29, no. 8, pp. 983–996, 2005.
- D. G. Sheppard and H. I. Libshitz, “Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases,” Clinical Radiology, vol. 56, no. 1, pp. 22–29, 2001.
- W. Shon, S. M. Jenkins, D. T. Ross et al., “Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness,” Journal of Cutaneous Pathology, vol. 38, no. 12, pp. 961–966, 2011.
- A. T. Deyrup, J. K. McKenney, M. Tighiouart, A. L. Folpe, and S. W. Weiss, “Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases,” American Journal of Surgical Pathology, vol. 32, no. 1, pp. 72–77, 2008.
- R. A. Gladdy, L.-X. Qin, N. Moraco et al., “Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?” Journal of Clinical Oncology, vol. 28, no. 12, pp. 2064–2069, 2010.
- M. T. Scott, L. H. Portnow, C. G. Morris et al., “Radiation therapy for angiosarcoma: the 35-year university of Florida experience,” American Journal of Clinical Oncology, vol. 36, no. 2, pp. 174–180, 2013.
- M. S. Mano, G. Fraser, J. Kerr et al., “Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy,” Breast, vol. 15, no. 1, pp. 117–118, 2006.
- E. Perez-Ruiz, N. Ribelles, A. Sanchez-Muñoz, A. Roman, and A. Marquez, “Response to paclitaxel in a radiotherapy-induced breast angiosarcoma,” Acta Oncologica, vol. 48, no. 7, pp. 1078–1079, 2009.
- N. Penel, B. N. Bui, J.-O. Bay et al., “Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study,” Journal of Clinical Oncology, vol. 26, no. 32, pp. 5269–5274, 2008.